| Source Date | Board Meeting Date | Details |
|
20-Mar-2025
|
25-Mar-2025
|
Inter-alia to: (a) Taking permission from the board for seeking approval of members of the Company by way of Special Resolution for Regularization of appointment of Mr. Sridhar Ramachandran (DIN: 07706213) from additional Independent Director to Independent Director. (b) To approve the draft Notice of Postal Ballot incorporating the proposed resolution and explanatory statement and to undertake all the necessary steps thereof.
|
|
27-Jan-2025
|
03-Feb-2025
|
Quarterly Results
|
|
18-Oct-2024
|
26-Oct-2024
|
Quarterly Results
|
|
01-Aug-2024
|
09-Aug-2024
|
Quarterly Results
|
|
09-May-2024
|
15-May-2024
|
Quarterly Results & Final Dividend & Audited Results
|
|
20-Mar-2024
|
23-Mar-2024
|
Inter alia, to consider and approve: - To consider and approve fund raising by way issue of securities including securities and warrants convertible into non convertible debt instruments Subject to approval of Board of Directors and approvals from the other regulatory authorities as may be required
|
|
16-Feb-2024
|
24-Feb-2024
|
Inter alia, to consider the following proposal: - 1) To take note of the performance evaluation of the Independent Directors for the financial year 2023-24 2) To consider and discuss the appointment of Ms. Tasneem Marfatia as company secretary and compliance officer of the company. 3) To take note of the terms of appointment of the Directors and Key Managerial Personnel and evaluation of increase / decrease in remuneration as per the performance evaluation submitted and taken on table by the board. 4) To consider any other matter with the permission of the Chair.
|
|
02-Feb-2024
|
12-Feb-2024
|
Quarterly Results
|
|
31-Oct-2023
|
07-Nov-2023
|
Quarterly Results & Inter alia, to consider:- b) To consider and approve the appointment of Chairman of Audit and Nomination & Remuneration Committee c) To consider and approve fund raising by way of issue of share warrants or any other securities through private placement/preferential issue or through any other permissible mode and/ or combination thereof as may be considered appropriate subject to approval from the shareholders and approvals from the other regulatory authorities as may be required.
|
|
04-Aug-2023
|
11-Aug-2023
|
Quarterly Results (Revised)
|